Wouldn't inhibiting nucleotide production already be explored well for cancer targets?
Isnt the only new thing here that they profiled and used senescent HMEC cells?
It seems they already had pharmaceutical and genetic means to target the protein already.
Wouldn't inhibiting nucleotide production already be explored well for cancer targets?
Isnt the only new thing here that they profiled and used senescent HMEC cells?
It seems they already had pharmaceutical and genetic means to target the protein already.